转自：贵州日报 "咱们的产品检测不含苯并芘和塑化剂，这是核心竞争力！"梁勇跃介绍，目前，中椒生物已斩获 HACCP体系认证、国际清真认证等多项国际资质，手握12项辣椒提取专利。产品75%用于出口，远销 东南亚以及北美洲、欧洲等地，"年销售额达8000万元，年出口额就占5000万元。"梁勇跃说。 一个火红的辣椒，经过现代化精深加工，正成为贵州向世界亮出的"味觉名片"。 另一边，提取后的辣椒油通过蒸发系统脱溶、脱胶，再进入冷却系统。"每一批产品都要经过层层化 验，合格了才能入库，这是品质的硬保障。"中椒生物研发中心主任刘盼盼手持抽样管，从生产线上中 下三层分别取样混合。 "8吨干辣椒只能萃取1吨辣椒油树脂，每吨价值超60万元。"中椒生物副总经理解滨道出产品的珍贵之 处：依托超临界二氧化碳萃取技术，相较于原料辣椒，提取后的产品价值提升30%至50%。 从食品增香、化妆品着色到医药行业，这些高纯度辣椒提取物的应用场景十分广泛。此外，中椒生物还 推出了辣椒红色素、辣椒粉、花椒油树脂、叶黄素、姜黄素等多种产品。 本报讯（记者 蒋洪飞）"前两天，公司16吨辣椒油树脂刚刚发往印度。"1月12日，遵义市播州区石板镇 国际辣椒产 ...

Core Insights - The company Tianhao Biotechnology has developed a new processing technology for chili peppers, enabling the production of high-purity chili oil resin and natural capsaicin crystals, meeting the demands of high-end markets [1][2] - The company aims to achieve an annual revenue of 250 million yuan once all production lines are operational, leveraging a high solvent recovery rate of 97% to reduce production costs by 50% compared to competitors [2] - The local chili industry, supported by decades of cultivation history and government initiatives, is transitioning from raw planting to high-value product processing, contributing significantly to the county's economic development [3] Company Overview - Tianhao Biotechnology has established standardized production facilities capable of processing 5,000 tons of dried chili peppers annually, with a daily output of 800 kg of natural capsaicin or 10 tons of chili oil resin [1] - The company’s products are characterized by high purity (over 98%), low impurities, strong stability, and compliance with high-quality standards for natural food additives [1][2] Industry Context - The local area, known as the "Hometown of Chili Peppers" in China, has a long history of chili cultivation, with 200,000 acres dedicated to growing spicy peppers and the largest chili wholesale market in northern Henan [2][3] - The government has implemented a "special class + mechanism" service model to support the transformation of the agricultural industry towards deep processing and high-tech projects, addressing challenges in financing, labor, technology, and marketing [3]

Core Points - The stock price of Morning Light Bio has increased by 66.12% this year, with a recent rise of 8.85% in the last five trading days [2] - The company reported a revenue of 3.658 billion yuan for the first half of 2025, representing a year-on-year growth of 4.77%, and a net profit of 215 million yuan, which is a significant increase of 115.33% year-on-year [3] - Morning Light Bio has a market capitalization of 6.894 billion yuan and a trading volume of 96.9973 million yuan as of October 15 [1] Financial Performance - The company has seen a net outflow of 1.5082 million yuan in principal funds, with large orders accounting for 16.83% of purchases and 19.20% of sales [1] - The company has cumulatively distributed 516 million yuan in dividends since its A-share listing, with 213 million yuan distributed in the last three years [4] Shareholder Information - As of June 30, the number of shareholders for Morning Light Bio is 15,800, a decrease of 35.12% from the previous period, while the average circulating shares per person increased by 54.14% to 25,224 shares [3] - The top ten circulating shareholders have changed, with the China Europe Times Pioneer Stock A exiting the list [4]

Group 1 - The core viewpoint of the news is that Morning Light Bio has seen a stock price increase of 5.07%, reaching 13.26 CNY per share, with a total market capitalization of 6.406 billion CNY [1] - Morning Light Bio, established on April 12, 2000, and listed on November 5, 2010, specializes in the research, production, and sales of natural plant extracts, including chili red pigment, lutein, chili oil resin, lycopene, and cottonseed protein [1] - The company's main business revenue composition is as follows: cottonseed-related business accounts for 48.25%, pigment/spice/nutritional and medicinal products account for 47.39%, and others account for 4.35% [1] Group 2 - From the perspective of fund holdings, one fund under China Europe Fund has a significant position in Morning Light Bio, with the China Europe Value Selection Mixed A Fund holding 581,300 shares, representing 2.43% of the fund's net value [2] - The China Europe Value Selection Mixed A Fund has achieved a year-to-date return of 22.87% and a one-year return of 39.76%, ranking 4202 out of 8171 and 3898 out of 8004 respectively [2] - The fund manager, Zhang Xueming, has been in position for 1 year and 157 days, with the fund's total asset size at 1.711 billion CNY and the best return during his tenure being 70.87% [3]